BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial
Abstract Objectives The BCG vaccine, widely used in Brazil in new-borns, induces adjuvant protection for several diseases, including childhood virus infections. BCG activates monocytes and innate memory NK cells which are crucial for the antiviral immune response. Therefore, strategies to prevent CO...
Main Authors: | Ana Paula Junqueira-Kipnis, Laura Raniere Borges dos Anjos, Lília Cristina de Souza Barbosa, Adeliane Castro da Costa, Kellen Christina Malheiros Borges, Amanda da Rocha Oliveira Cardoso, Kaio Mota Ribeiro, Sarah Brena Aparecida Rosa, Carine de Castro Souza, Rogério Coutinho das Neves, Guylherme Saraiva, Sueli Meira da Silva, Erika Aparecida da Silveira, Marcelo Fouad Rabahi, Marcus Barreto Conte, André Kipnis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-020-04822-0 |
Similar Items
-
The safety of BCG revaccination in the context of COVID-19
by: Adriana Sánchez-García, et al.
Published: (2023-12-01) -
Safety of BCG vaccination and revaccination in healthcare workers
by: Paola Villanueva, et al.
Published: (2023-08-01) -
Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease
by: Banurekha Velayutham, et al.
Published: (2023-01-01) -
Immunogenicity and Protection against <i>Mycobacterium caprae</i> Challenge in Goats Vaccinated with BCG and Revaccinated after One Year
by: Claudia Arrieta-Villegas, et al.
Published: (2020-12-01) -
BCG vaccination strategies against tuberculosis: updates and perspectives
by: Mengjin Qu, et al.
Published: (2021-12-01)